CN1058404C - Hepatitis B treating medicament - Google Patents
Hepatitis B treating medicament Download PDFInfo
- Publication number
- CN1058404C CN1058404C CN96101164A CN96101164A CN1058404C CN 1058404 C CN1058404 C CN 1058404C CN 96101164 A CN96101164 A CN 96101164A CN 96101164 A CN96101164 A CN 96101164A CN 1058404 C CN1058404 C CN 1058404C
- Authority
- CN
- China
- Prior art keywords
- medicine
- hepatitis
- medicines
- preparation
- invigorating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 29
- 241000208340 Araliaceae Species 0.000 claims abstract description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 7
- 244000268590 Euryale ferox Species 0.000 claims description 3
- 235000006487 Euryale ferox Nutrition 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 210000003038 endothelium Anatomy 0.000 claims description 3
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 210000003734 kidney Anatomy 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 239000006187 pill Substances 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 241000700721 Hepatitis B virus Species 0.000 abstract description 3
- 210000005229 liver cell Anatomy 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 230000003908 liver function Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 5
- 230000002085 persistent effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 201000001862 viral hepatitis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a Minglongganbao medicine for treating hepatitis B and a preparation method thereof. The medicine belongs to a traditional Chinese medicine for treating hepatitis B, and is especially suitable for patients with persistent hepatitis B and people in weak health. The medicine comprises medicines for invigorating the spleen and benefiting qi, medicines for invigorating the kidney and nourishing yin, medicines for dispersing stagnated liver qi and regulating the stomach and medicines for clearing heat and detoxifying toxin, wherein the medicines for invigorating the spleen and benefiting qi comprise ginseng. The preparation method of the medicine comprises a preparation method of pills and a preparation method of medicinal powder. For the formula of pills, the dosage is 5 to 60 grams for each time and 2 to 3 times for each day; for the formula of medicinal powder, the dosage is from 5 to 48 grams each time and from 2 to 3 times each day. The Minglongganbao medicine for treating hepatitis B of the present invention has the advantages of obvious effect and high negative conversion rate. The medicine effectively improves the immunity of human bodies, inhibits and clears hepatitis B viruses, improves hepatic functions and promotes the regeneration of liver cells.
Description
The present invention relates to a kind of medicine for the treatment of hepatitis B, belong to treatment hepatitis B Chinese medicine, be specially adapted to the empty hepatitis B patient of body of protracted course of disease.
Type B viral hepatitis is called for short hepatitis B or hepatitis B, is a kind of common and multiple infectious disease.The record of a large amount of similar primary disease performances is arranged, most generic " hypochondriac pain ", " jaundice ", disease categories such as " gathering " in motherland's medical science.The Chinese medicine weak point of existing treatment hepatitis B is, for the empty hepatitis B patient of the body of chronic protracted course of disease, lacks a kind of medicine that can effectively, fast, stably improve body immunity and inhibition, removing hepatitis B virus, promote liver cell regeneration.
The objective of the invention is to, overcome the deficiency that existing therapeutic agent for hepatitis B exists, provide a kind of and set upright to effect a permanent cure, it is main promptly improving body immunity, and to uncharm, promptly detoxifcation is auxilliary, reaches the purpose for the treatment of hepatitis B effectively thereby hold concurrently with depressed liver-energy dispersing and QI regulating.
The component and the weight ratio of the composition medicine of hepatitis B medicine of the present invention are: Radix Ginseng 0.5, Semen Cuscutae 0.2, Rhizoma Dioscoreae 0.15, Rhizoma Atractylodis Macrocephalae preparata 0.1, Poria 0.15, Radix Rehmanniae Preparata 2.6, Fructus Ligustri Lucidi 0.2, Semen Euryales 0.2, Chinese 0.1, Pericarpium Citri Reticulatae 0.1, Radix Aucklandiae (Radix Vladimiriae) 0.2 is fried Endothelium corneum 0.1, Fructus Amomi Rotundus 0.1, Herba Hedyotidis Diffusae 0.1, Herba Epimedii 0.2; Preparation is made conventional dose.
Hepatitis B medicine of the present invention, its Radix Ginseng can be Jilin Radix Ginseng, can be wild ginseng, or the artificial culture Radix Ginseng.Wild ginseng best results in the Jilin Radix Ginseng wherein, the content of Radix Ginseng in prescription when preparing metering by consumption per day with pill or powder, is the 0.1-15 gram.
The compounding method of hepatitis B medicine of the present invention: can be made into pill, or powder, or decoction.Its pill is after Chinese herbal medicine is prepared, and is total to the porphyrize powder, and Radix Rehmanniae Preparata is endured cream then, refines close one-tenth ball, and the size of its ball was obeyed 2-3 time with day, and each 5-60 gram quantitatively.Its powder is with Chinese herbal medicine classification processing, pulverize altogether, and dosing per diem, or each amount packing then, day clothes 2-3 time, each 5-48 gram is quantitative.Above-mentioned compounding method gained pill or powder, independent system is joined, and can independently use, and various dosage forms respectively have convenient and effect part.
Hepatitis B medicine of the present invention mainly uses with pill-type, makes simple, easy to use.
Hepatitis B medicine of the present invention is the principle according to modern pharmacology, and the method that adopts differential diagnosis in tcm and doctor trained in Western medicine to debate disease develops.Type B viral hepatitis is called for short hepatitis B, or claims hepatitis B, is a kind of common and multiple infectious disease.The traditional Chinese medical science is thought, blood stored in the liver, and main catharsis, body is cloudy and with sun, the thin smooth bar of property happiness reaches; This onset of disease, insufficiency of the spleen stagnation of liver-QI, catharsis incapability, functional activity of QI being not smooth; Hepatopathy with the passing of time, transverse invasion of hyperactive liver-QI, more imapirment of the spleen and stomach, so that weakness of the spleen and stomach, failing of the spleen to transport is received impermanence; The liver and the kidney have a common source, and hepatopathy is prolonged for a long time and do not healed, and edema with the liver involved is lost it and grown flourishly, very then involves in kidney.Based on strengthening spleen, tonifying kidney, effect a permanent cure scheming in the hepatitis B prescription of the present invention, hold concurrently, be aided with the method for detoxifcation with depressed liver-energy dispersing and QI regulating.Radix Ginseng, particularly Jilin Radix Ginseng, Gan Wen, go into spleen channel, invigorating the spleen and replenishing QI, strongly invigorating primordial QI is aided with other tonifying kidney and nourishing yin medicine such as Semen Cuscutae, but the kidney invigorating and essence nourishing, temperature compensating below element.The all medicine compatibilities in full side must be mended hepatitis B patient spleen kidney, irritability must with, mechanism of qi is orderly and clearly, and makes clearing moist heat, accumulates poison and separates, and is chronic viral hepatitis B patient's good recipe.
Concrete formula examples is as follows, and measurement unit is a day dosing gram: Radix Ginseng 0.5, Semen Cuscutae 0.2, Rhizoma Dioscoreae 0.15 Rhizoma Atractylodis Macrocephalae preparata 0.1, Poria 0.15, Radix Rehmanniae Preparata 2.6, Fructus Ligustri Lucidi 0.2, Semen Euryales 0.2, Chinese 0.1, Pericarpium Citri Reticulatae 0.1, Radix Aucklandiae (Radix Vladimiriae) 0.2 is fried Endothelium corneum 0.1, Fructus Amomi Rotundus 0.1, Herba Hedyotidis Diffusae 0.1, Herba Epimedii 0.2.
Hepatitis B medicine of the present invention, its instructions of taking is:, give up alcohol and raw food with being the best with (medicine) being taken before meal.
The present inventor is opening up invention on the basis of proved recipe, and this invention hepatitis B medicine carried out a large amount of clinical verifications, effect is remarkable, the negative conversion rate height, improved body immunity effectively, suppress, remove hepatitis B virus, improve liver function, promote liver cell regeneration, simultaneously, detect through the parties concerned, hepatitis B medicine of the present invention meets the safety criterion of the acute toxicity test of new drug, and is without any side effects.
Claims (1)
1, a kind of medicine for the treatment of hepatitis B is characterized in that, component and the weight ratio of forming medicine are: Radix Ginseng 0.5, Semen Cuscutae 0.2, Rhizoma Dioscoreae 0.15, Rhizoma Atractylodis Macrocephalae preparata 0.1, Poria 0.15, Radix Rehmanniae Preparata 2.6, Fructus Ligustri Lucidi 0.2, Semen Euryales 0.2, Chinese 0.1, Pericarpium Citri Reticulatae 0.1, Radix Aucklandiae (Radix Vladimiriae) 0.2 is fried Endothelium corneum 0.1, Fructus Amomi Rotundus 0.1, Herba Hedyotidis Diffusae 0.1, Herba Epimedii 0.2; Preparation is made conventional dose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96101164A CN1058404C (en) | 1996-02-27 | 1996-02-27 | Hepatitis B treating medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96101164A CN1058404C (en) | 1996-02-27 | 1996-02-27 | Hepatitis B treating medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1158253A CN1158253A (en) | 1997-09-03 |
| CN1058404C true CN1058404C (en) | 2000-11-15 |
Family
ID=5116982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96101164A Expired - Fee Related CN1058404C (en) | 1996-02-27 | 1996-02-27 | Hepatitis B treating medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058404C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1089503A (en) * | 1993-09-24 | 1994-07-20 | 肖才松 | Gantaibao capsule and production technology thereof |
| CN1100642A (en) * | 1993-09-22 | 1995-03-29 | 李彤 | Chinese medicine preparation for treating viral hepatitis B |
-
1996
- 1996-02-27 CN CN96101164A patent/CN1058404C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1100642A (en) * | 1993-09-22 | 1995-03-29 | 李彤 | Chinese medicine preparation for treating viral hepatitis B |
| CN1089503A (en) * | 1993-09-24 | 1994-07-20 | 肖才松 | Gantaibao capsule and production technology thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1158253A (en) | 1997-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1044974C (en) | Anti- hepatitis B preparation | |
| CN100363022C (en) | Pharmaceutical composition with immunoregulation function and method for preparing the same | |
| CN102755594A (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN101757561A (en) | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof | |
| CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
| CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
| CN1055638C (en) | Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method | |
| CN102048902B (en) | A traditional Chinese medicine composition, extract, preparation method, application and dosage form for treating hepatitis | |
| CN1232288C (en) | Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process | |
| CN1058404C (en) | Hepatitis B treating medicament | |
| CN105362904A (en) | Qi tonifying and blood nourishing traditional Chinese medicinal pill and preparation method thereof | |
| CN104042895A (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus and use thereof | |
| CN1059811C (en) | Complete set of Chinese medicine preparations for curing hepatitis B | |
| CN101088555B (en) | Medicine preparation for inhibiting tumor angiogenesis and cancer cell and enhancing immunity | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B | |
| CN101695562A (en) | Chinese medicinal composition for treating viral hepatitis and preparation method thereof | |
| CN101190306B (en) | Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof | |
| CN1102591A (en) | Three-seedling compound mixture and formula thereof | |
| CN109464589A (en) | A kind of blood-enriching soup and preparation method thereof | |
| CN101804159B (en) | Traditional Chinese medicine preparation for treating aplastic anemia | |
| CN101288683A (en) | Application of roselle in preparation of health care product with lead-removing effect | |
| CN1176673C (en) | Compound and powder prescription | |
| CN1086949C (en) | Chinese medicine for hepatitis B and its preparation | |
| CN1305504C (en) | Medicine for treating hepatitis | |
| CN120617392A (en) | Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating sarcopenia related to metabolic-related fatty liver disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |